Overview

Intervention Study for Individuals With Compulsive Sexual Behavior

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
0
Participant gender:
Male
Summary
The purpose of this study is compare three interventions (short-term psychodynamic psychotherapeutic group and relapse prevention group therapy vs. treatment as usual, namely, psychiatric follow up including prescription of medication vs. both interventions combined) to individuals presenting compulsive sexual behavior.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Sao Paulo General Hospital
Treatments:
Serotonin Uptake Inhibitors
Criteria
Inclusion Criteria:

1. meeting the criteria for "excessive sexual drive" (ICD-10 F52.7) which corresponds to
complain of an excessive sexual drive that often leads to out of control sexual
behaviors AND meeting the criteria for "sex addiction" by Goodman (2001), which is
characterized as a maladaptive pattern of sexual behavior leading to clinically
impairment or distress as manifested in the same 12-month period by three or more of
the following: tolerance (process of engaging in increasingly sexual behavior, in
terms of intensity and frequency to obtain the same satisfaction than before);
withdrawal (experience of abstinence, characterized by the presence of physical and/or
psychological symptoms, when the behavior is diminished or discontinued); frequent
sexual behavior; unsuccessful efforts to control it; many time spent in preparation
for it; social or occupational activities are diminished because of it; it goes on
despite negative outcomes;

2. being literate in Portuguese;

3. cognitive ability to answer self-responsive measures.

Exclusion Criteria: - individuals who met criteria for:

1. sexual preference disorders (ICD-10 F65);

2. manic or hypomanic state of bipolar disorder (ICD-10 F30.0, F31.0, 31.1, and 31.2);

3. schizophrenia, schizotypal, and delusional disorders (ICD-10 F20 - F29);

4. other mental disorders due to brain dysfunction, injury or physical disease (ICD-10
F06);

5. gender identity disorder (ICD-10 F64).